Provided by Tiger Fintech (Singapore) Pte. Ltd.

Applied Therapeutics Inc.

0.4749
+0.01493.24%
Post-market: 0.4673-0.0076-1.60%19:51 EDT
Volume:903.63K
Turnover:420.68K
Market Cap:67.23M
PE:-1.56
High:0.4780
Open:0.4600
Low:0.4438
Close:0.4600
Loading ...
Aug 04, 2022

Major Issues Report

8-K - Current report
Jul 08, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 29, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jun 27, 2022

Major Issues Report

8-K - Current report
Jun 03, 2022

Major Issues Report

8-K - Current report
May 12, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 12, 2022

Major Issues Report

8-K - Current report
Mar 10, 2022

Major Issues Report

8-K - Current report
Mar 10, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 15, 2022

Major Issues Report

8-K - Current report
Feb 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 28, 2022

Major Issues Report

8-K - Current report
Jan 28, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jan 26, 2022

Major Issues Report

8-K - Current report
Jan 04, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Sep 14, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Aug 11, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Jul 29, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Jul 15, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities